• Research
    • Research groups
    • Functional Genomics Area
    • Strategic Line 1: The Human Genome
    • Strategic Line 2: Cancer Genomics
    • Personalised Medicine Area
    • Strategic Line 3: Detection, Diagnostics, Monitoring and Prognostics of Diseases
    • Strategic Line 4: Advanced Therapies
    • Publications
    • International Projects

There are no projects in the garbage can.

  • WebMail
  • Private area
  • Español
  • Center
    • What is GENyO?
    • Support Units
    • Management Units
    • Strategic Plan 2024-2027
    • Transparency
    • Contact
  • Events and news
    • News
    • Events
    • Scientific Conferences
    • Galleries
  • GENyO TV
  • Research
    • Research groups
    • Functional Genomics Area
    • Strategic Line 1: The Human Genome
    • Strategic Line 2: Cancer Genomics
    • Personalised Medicine Area
    • Strategic Line 3: Detection, Diagnostics, Monitoring and Prognostics of Diseases
    • Strategic Line 4: Advanced Therapies
    • Publications
    • International Projects
  • Center
    • What is GENyO?
    • Support Units
    • Management Units
    • Strategic Plan 2024-2027
    • Transparency
    • Contact
  • Events and news
    • News
    • Events
    • Scientific Conferences
    • Galleries
  • GENyO TV
  • WebMail
  • Private area
  • Español

There are no projects in the garbage can.

International Projects

diaRNAgnosis

Home

diaRNAgnosis

diaRNAgnosis

GenE-Humdi – Genome Editing for the treatment of human Disease Network

GenE-Humdi – Genome Editing for the treatment of human Disease Network

Program SPARK THERAPUTICS INC

Program SPARK THERAPUTICS INC

3TR

3TR

Research

Publications

See more

Insight into the epigenetic regulation of gene expression in the bloodstream and procyclic forms of Trypanosoma brucei through the involvement of G-quadruplexes.

Authors: Belmonte-Reche E, Martínez-García M, de Jong A, Kuipers OP, Cebrián R

07/2025 - NAR genomics and bioinformatics

Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosus.

Authors: Lindblom J, Barturen G, Beretta L, Toro-Domínguez D, Carnero-Montoro E, Borghi MO, Castillo J, Iacobaeus E, Enman Y, PRECISESADS Clinical Consortium, Mohan C, Alarcón-Riquelme ME, Nikolopoulos D, Parodis I

06/2025 - Journal of translational autoimmunity

Investigation of HLA-B -21 M/T Dimorphism and Its Potential Role in COVID-19.

Authors: Martín-Rodríguez D, Gutiérrez-Bautista JF, Bernal M, Rodriguez-Nicolas A, Vílchez JR, Marín-Sánchez A, Rosales-Castillo A, Sainz J, Cabrera-Serrano AJ, Ceron-Hernandez J, López-Nevot MÁ, Ruiz-Cabello F, Jiménez P

07/2025 - International journal of molecular sciences

    Transparency

  • Documents of interest
  • Organizational structure
  • Organizational chart

    Research

  • Research groups
  • Functional Genomics Area
  • Personalised Medicine Area
  • International Projects
  • Publications

    Center

  • What is GENyO?
  • Support Units
  • Management Units
  • Strategic Plan 2024-2027
  • Transparency
  • Contact

    Events and news

  • News
  • Events
  • Scientific Conferences
  • Galleries

Address

Avda. de la Ilustración 114.
18016 Granada, Spain

+34 958 715 500
info@genyo.es
  • Company affiliation

    2025 @Genyo All rights reserved

  • Legal note
  • Cookies Policy
  • Privacy Policy